Internet-delivered Cognitive Behavioural Therapy in Arabic for Anxiety and Depression

Culturally Adapted Transdiagnostic Internet-delivered Cognitive Behavioural Therapy in Arabic for Anxiety and Depression

The purpose of this study is to evaluate the efficacy of a culturally adapted internet-administrated cognitive behaviour therapy (ICBT) in Arabic for anxiety and depression

Study Overview

• Status: Completed
• Conditions: Depression; Anxiety
• Intervention / Treatment: Behavioral: Internet-delivered CBT

Detailed Description

The study will compare the effect of the intervention against a wait-list control. The intervention tested is based on cognitive behavior therapy delivered over the internet via a secure treatment platform. Participants in the study are recruited from the general public via social media. The intervention is in Arabic.

• Study Type: Interventional
• Enrollment (Actual): 59
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Sweden
  • Linköping, Sweden, 581 83
    • Linköping University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 65 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Be above 18 years of age
• Have symptoms of anxiety and/or depression
• Be able to read and write in Arabic
• Have access to computer or smartphone

Exclusion Criteria:

• Suicidal ideation
• Alcohol addiction
• Other major primary psychiatric disorder
• Ongoing psychological treatment
• Recent (during last 4 weeks) change in psychiatric medication

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Internet CBT; Internet-based cognitive behavioural therapy in Arabic with therapeutic guidance through email.	Behavioral: Internet-delivered CBT; Culturally adapted transdiagnostic internet-delivered CBT in Arabic
No Intervention: Wait-list; Wait-list control

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in Patient Health Questionnaire (PHQ-9)	The PHQ-9 is a nine-item self-report questionnaire that measures symptoms of depression. It is scored from 0-27 with a higher score reflecting more severe symptoms.	pre-treatment ,week 3, week 6, week 8 and 12 months post-treatment
Change in Generalised Anxiety Disorder-7-item scale, (GAD-7)	The GAD-7 is a seven-item self-report questionnaire that measures symptoms of anxiety. It is scored from 0-21 with a higher score reflecting more severe symptoms.	pre-treatment ,week 3, week 6, week 8 and 12 months post-treatment

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Alcohol Use Disorder Identification Test (AUDIT)	Measures alcohol consumption, drinking behaviors, and alcohol-related problems. It is scored from 0-40 with higher scores reflecting more alcohol consumption, drinking behaviors, and alcohol-related problems.	pre-treatment, week 8
Insomnia Severity Index (ISI)	Self-reported symptoms of insomnia. It is scored from 0-28 with higher scores reflecting more symptoms of insomnia.	pre-treatment, week 8
Impact of Events Scale - Revised (IES-R)	Self-reported symptoms of post-traumatic stress. It is scored from 0-88 where higher scores reflect more symptoms.	pre-treatment, week 8
Perceived Stress Scale (PSS)	Self-reported stress-related symptoms. It is scored from 0-56 with higher scores reflecting more symtoms of perceived stress.	pre-treatment, week 8
"Brunnsviken Brief Quality of Life Scale" (BBQ)	Self-reported quality of life. The scale is scored from 0-96 with a higher score reflecting higher self-reported quality of life.	pre-treatment, week 8

Collaborators and Investigators

• Sponsor: Linkoeping University

Study record dates

Study Major Dates

• Study Start (Actual): January 7, 2019
• Primary Completion (Actual): December 1, 2019
• Study Completion (Actual): December 1, 2019

Study Registration Dates

• First Submitted: March 29, 2018
• First Submitted That Met QC Criteria: April 5, 2018
• First Posted (Actual): April 12, 2018

Study Record Updates

• Last Update Posted (Actual): February 20, 2020
• Last Update Submitted That Met QC Criteria: February 19, 2020
• Last Verified: February 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Behavioral Symptoms; Mental Disorders; Mood Disorders; Depression; Depressive Disorder; Anxiety Disorders
• Other Study ID Numbers: SAHA

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No